USD
+$0.00
(+0.00%
)At Close (As of Sep 9, 2025)
$129.60M
Market Cap
-
P/E Ratio
-0.27
EPS
$1.53
52 Week High
$0.32
52 Week Low
HEALTHCARE
Sector
Field | Value (CAD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$35M |
Selling General And Administrative | $13M |
Research And Development | $22M |
Operating Expenses | $35M |
Investment Income Net | - |
Net Interest Income | $1.2M |
Interest Income | $1.2M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $102K |
Income Before Tax | -$32M |
Income Tax Expense | $130K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$32M |
Comprehensive Income Net Of Tax | - |
Ebit | -$35M |
Ebitda | -$35M |
Net Income | -$32M |
Field | Value (CAD) |
---|---|
Total Assets | $20M |
Total Current Assets | $19M |
Cash And Cash Equivalents At Carrying Value | $16M |
Cash And Short Term Investments | $16M |
Inventory | - |
Current Net Receivables | $68K |
Total Non Current Assets | $1.3M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $2.9M |
Other Non Current Assets | - |
Total Liabilities | $14M |
Total Current Liabilities | $6.7M |
Current Accounts Payable | $1.1M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $277K |
Total Non Current Liabilities | $7.5M |
Capital Lease Obligations | $1.1M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.1M |
Other Current Liabilities | $5.3M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $6M |
Treasury Stock | - |
Retained Earnings | -$478M |
Common Stock | $438M |
Common Stock Shares Outstanding | $76M |
Field | Value (CAD) |
---|---|
Operating Cashflow | -$27M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $424K |
Capital Expenditures | $239K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$239K |
Cashflow From Financing | $6.6M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$32M |
Field | Value (CAD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$35M |
Selling General And Administrative | $13M |
Research And Development | $22M |
Operating Expenses | $35M |
Investment Income Net | - |
Net Interest Income | $1.2M |
Interest Income | $1.2M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $102K |
Income Before Tax | -$32M |
Income Tax Expense | $130K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$32M |
Comprehensive Income Net Of Tax | - |
Ebit | -$35M |
Ebitda | -$35M |
Net Income | -$32M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. The company is headquartered in Calgary, Canada.